Integrated Filing — IndAS



General information about company
Scrip Code 540268
NSE Symbol TRU
MSEI Symbol NOTLISTED
ISIN INE615R01029
Name of company TRUCAP FINANCE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 26-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 21-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment NA
Start date and time of board meeting 26-May-2025   16:15:00
End date and time of board meeting 26-May-2025   19:05:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2022-08-03
Indicate Company website link for updated RPT policy of the Company https://trucapfinance.com/wp-content/uploads/Policy-on-RPT.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 353151000 1964156000
Other income 7244000 28405000
Total income 360395000 1992561000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
(d) Employee benefit expense 109519000 475867000
(e) Finance costs 207501000 986912000
(f) Depreciation, depletion and amortisation expense 79041000 140894000
(f) Other Expenses
1 Other expenses 132590000 427258000
Total other expenses 132590000 427258000
Total expenses 1205052000 2777687000
3 Total profit before exceptional items and tax -844657000 -785126000
4 Exceptional items 0 0
5 Total profit before tax -844657000 -785126000
6 Tax expense
7 Current tax -29842000 2952000
8 Deferred tax -110466000 -122025000
9 Total tax expenses -140308000 -119073000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement
11 Net Profit Loss for the period from continuing operations -704349000 -666053000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period -704349000 -666053000
17 Other comprehensive income net of taxes -5015000 -4496000
18 Total Comprehensive Income for the period -709364000 -670549000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 233799000 233799000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 1388118000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -6.03 -5.7
Diluted earnings (loss) per share from continuing operations -6.03 -5.7
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -6.03 -5.7
Diluted earnings (loss) per share from continuing and discontinued operations -6.03 -5.7
24 Debt equity ratio 0.0321 0.0321
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) Notes: n3 The above results for the quarter and year ended March 31, 2025 have been reviewed and recommended by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective meetings held on May 26, 2025. n4 The audited standalone financial results for the quarter and year ended March 31, 2025 have been audited by the Statutory Auditors and they have issued an unmodified opinion. n5 The Company has primarily two reportable business segments namely Fund based Activities and Advisory services for the quarter and year ended March 31, 2025. The Company publishes audited standalone financial results along with the audited consolidated financial results and in accordance with Ind AS 108 - Operating Segments, the Company has disclosed the segment information in the audited consolidated financial results of the Company. n6 Fees and commission income includes advisory service fees and commission from syndication loan. n7 With respect to the preferential issues made by the Company under SEBI Issue of Capital and Disclosure Requirements Regulations, 2018, as amended, ICDR Regulations, there are no deviation or category wise variation in utilization of funds pursuant to Regulation 32 of Listing Regulations. Further, 65,42,372 convertible warrants allotted on February 01, 2024 at an issue price of Rs.73.75/- per warrant and are outstanding as on March 31, 2025 and 75% consideration in terms with the ICDR Regulations are pending to be received. Further, during the quarter ended March 31, 2025, based on the communication from the warrant holder voluntarily waiving his right to exercise 55,74,912 Warrants, as a result, 55,74,912 Warrants stand cancelled. Consequently, upfront consideration of Rs 9,99,99,984/- representing 25% of the total consideration received received by the Company towards 55,74,912 warrants is forfeited, in accordance with the terms of the warrants and the provisions of Regulation 1693 of ICDR Regulations. n8 During the quarter ended 31 March, 2025 the company has impaired its investment in subsidiary by Rs. 2109.36 Lakhs on account of continuing losses in subsidairy company. n9 The outstanding Non-Convertible Debentures NCDs as on March 31, 2025 are fully secured by hypothecation of book debts/ loan receivables to the extent as stated in the disclosure documents. The Company has, at all times, for the secured NCDs, maintained sufficient asset cover as stated in the disclosure documents. Further, additional line items in compliance with Regulation 52 4 of the Listing Regulations for the quarter ended March 31, 2025 is attached as Annexure 1 and the disclosure with respect to security cover certified by the Statutory Auditors as required under Regulation 543 of the Listing Regulations is enclosed as Annexure 2. Further, with respect to the said NCDs allotted, there is no material deviations in the use of issue proceeds of non-convertible securities from the objects of the issue stated in the disclosure documents. tttttttt n10 Disclosure pertaining to RBI Master Direction - RBI/DOR/2021-22/86 DOR.STR.REC.51/21.04.048/2021-22 Reserve Bank of India Transfer of Loan Exposures Directions, 2021 dated September 24, 2021. na Details of transfer through assignment in respect of loans not in default during the quarter ended March 31, 2025 ntCount of loans accountstttt5318 ntAmount of loan accounts Rs. In Lakhstttt4607.35 ntWeighted average maturity in monthstttt12 ntWeighted average remaining holding period in monthstttt10.39 ntRetention of beneficial economic interest%tttt10% - 20% ntCoverage of tangible security %tttt100% ntRating wise distribution of rated loansttttNA ntBreak-up of loans Transferred through assignmentttttAll Assignment ntInstances where we have agreed to replace loans transferred to transferees or pay damages arising out of any representation or warrantyttttNA nb The company has not acquired any loans not in default through assignment during the quarter ended March 31, 2025 nc The Company has neither acquired nor transferred any stressed loans during the quarter ended March 31, 2025 n11 The Board of Directors had at its meeting held on February 25, 2025, approved to sell the entire gold loan business of the Company along with the assets and liabilities pertaining to gold loan business, on a going concern basis to InCred Financial Services Limited “InCred”, by way of slump sale, subject to execution of long form documents and approval of the Shareholders of the Company and other such approvals as may be required. Further, the Board in its meeting held on May 26, 2025 has noted that due to certain factors outside the control of the Company and InCred, both the parties have decided to not proceed with the slump sale of the gold loan business. n12 Disclosure as required under Master Direction – Reserve Bank of India Securitisation of Standard Assets Directions, 2021, issued by the Reserve Bank of India on September 24, 2021, during the quarter ended March 31, 2025. ntCount of loans accountstttt7212 ntAmount of loan accounts Rs. In Lakhstttt1439.23 ntWeighted average maturity in monthstttt12 ntWeighted average remaining holding period in monthstttt10.39 ntRetention of beneficial economic interest%tttt3% ntCoverage of tangible security %tttt100% ntRating wise distribution of rated loansttttNA ntBreak-up of loans TransferredttttAll Assignment ntInstances where we have agreed to replace loans transferred to transferees or pay damages arising out of any representation or warrantyttttNA n13 The figures for the fourth quarter ended March 31, 2025 and quarter ended March 31, 2024 are balancing figures between audited figures in respect of the year ended March 31, 2025 and March 31, 2024 and the unaudited figures for the nine-months ended December 31, 2024 and unaudited figures for the nine-months ended December 31, 2024 respectively. n14 The figures for the previous quarter/year have been regrouped / rearranged wherever necessary to conform to the current quarter presentation. nFor and on behalf of the Board of TruCap Finance Limited nsd/- nRohanjeet Singh Juneja nManaging Director and Chief Executive Officer nDIN: 08342094 nMumbai, May 26, 2025



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 144050000
Capital work-in-progress
Investment property
Goodwill 0
Other intangible assets 60466000
Intangible assets under development 2626000
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments
Trade receivables, non-current
Loans, non-current
Other non-current financial assets
Total non-current financial assets
Deferred tax assets (net) 158321000
Other non-current assets
Total non-current assets
2 Current assets
Inventories 0
Current financial asset
Current investments
Trade receivables, current
Cash and cash equivalents 380612000
Bank balance other than cash and cash equivalents 580190000
Loans, current
Other current financial assets
Total current financial assets
Current tax assets (net)
Other current assets
Total current assets
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 6992371000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 233799000
Other equity 1388118000
Total equity attributable to owners of parent 1621917000
Non controlling interest
Total equity 1621917000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total non-current financial liabilities
Provisions, non-current
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities
Current liabilities
Current financial liabilities
Borrowings, current
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other current financial liabilities
Total current financial liabilities
Other current liabilities
Provisions, current
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 5370454000
Total equity and liabilites 6992371000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain/(loss) on defined benefit plan -2579000 -1892000
Total Amount of items that will not be reclassified to profit and loss -2579000 -1892000
2 Income tax relating to items that will not be reclassified to profit or loss -631000 -463000
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gain/(Loss) on hedging instrumentsn in cash flow hedges -4061000 -4061000
Total Amount of items that will be reclassified to profit and loss -4061000 -4061000
4 Income tax relating to items that will be reclassified to profit or loss -994000 -994000
5 Total Other comprehensive income -5015000 -4496000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax -785126000
Adjustments for reconcile profit (loss)
Adjustments for finance costs -71312000
Adjustments for decrease (increase) in inventories 0
Adjustments for decrease (increase) in trade receivables, current 283752000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -107711000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 229479000
Adjustments for other financial assets, current 621460000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -13200000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 45000
Adjustments for depreciation and amortisation expense 0
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 727966000
Adjustments for provisions, current 4142000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 1034306000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 497000
Adjustments for fair value losses (gains) -2143000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) -143000
Other adjustments for non-cash items 140894000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 2848032000
Net cash flows from (used in) operations 2062906000
Dividends received 0
Interest paid 0
Interest received -39120000
Income taxes paid (refund) -54181000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 2077967000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 1274739000
Other cash payments to acquire equity or debt instruments of other entities 1301306000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 8000
Purchase of property, plant and equipment 1987000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 39120000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -260523000
Net cash flows from (used in) investing activities -249949000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 100000000
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 3379900000
Repayments of borrowings 5934641000
Payments of lease liabilities 4602000
Dividends paid 1169000
Interest paid 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -2460512000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -632494000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -632494000
Cash and cash equivalents cash flow statement at beginning of period 1013106000
Cash and cash equivalents cash flow statement at end of period 380612000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Khandelwal Kakani & Company Yes 31-Oct-2026


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 TruCap Finance Limited DFL TECHNOLOGIES PVT LTD Other related parties Any other transaction Reimbursement of expenses 9078000 Approved 9078000 0 0
2 TruCap Finance Limited Prolific Ventures Pvt Ltd Other related parties Purchase of goods or services 7165000 Approved 3047000 0 0
3 TruCap Finance Limited Prolific Ventures Pvt Ltd Other related parties Purchase of goods or services 4436000 Approved 4436000 0 0
4 TruCap Finance Limited Prolific Ventures Pvt Ltd Other related parties Any other transaction Reimbursement of expenses 89000 Approved 89000 0 0
5 TruCap Finance Limited Ms. Abha Kapoor Director Any other transaction Sitting fees 0 As approved by the Board of Directors 250000 0 0
6 TruCap Finance Limited Mr. Krishipal Raghuvanshi Director Any other transaction Sitting fees 0 As approved by the Board of Directors 450000 0 0
7 TruCap Finance Limited Mr. Nirmal Vinod Momaya Director Any other transaction Sitting fees 0 As approved by the Board of Directors 400000 0 0
8 TruCap Finance Limited Mr. Rajiv Kapoor Director Any other transaction Sitting fees 0 As approved by the Board of Directors 400000 0 0
9 TruCap Finance Limited Ms. Rushina Nimir Mehta Director Any other transaction Sitting fees 0 As approved by the Board of Directors 200000 0 0
10 TruCap Finance Limited Mr. Rohanjeet Singh Juneja Director Remuneration 9435000 As approved by the Board of Directors 9435000 0 0
11 TruCap Finance Limited Mr. Rohanjeet Singh Juneja Director Any other transaction Reimbursement of expenses 2492000 As approved by the Board of Directors 2492000 356000 5000
12 TruCap Finance Limited Mr. Sanjay Kukreja Key Management Personnel (KMP) Remuneration 3574000 As approved by the Board of Directors 3574000 0 0
13 TruCap Finance Limited Mr. Sanjay Kukreja Key Management Personnel (KMP) Any other transaction Reimbursement of expenses 327000 As approved by the Board of Directors 327000 0 11000
14 TruCap Finance Limited Mr. Lalit Chendvankar Key Management Personnel (KMP) Remuneration 2749000 As approved by the Board of Directors 2749000 0 0
15 TruCap Finance Limited Mr. Lalit Chendvankar Key Management Personnel (KMP) Any other transaction Reimbursement of expenses 385000 As approved by the Board of Directors 385000 0 0
16 TruCap Finance Limited Ms. Sonal Sharma Key Management Personnel (KMP) Remuneration 1022000 As approved by the Board of Directors 1022000 0 0
17 TruCap Finance Limited Ms. Sonal Sharma Key Management Personnel (KMP) Any other transaction Reimbursement of expenses 74000 As approved by the Board of Directors 74000 0 0
Total value of transaction during the reporting period 38408000